tradingkey.logo
tradingkey.logo
Pesquisar

OptimizeRx Corp

OPRX
Adicionar à lista de desejos
6.190USD
+0.110+1.81%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
116.16MValor de mercado
16.76P/L TTM

Mais detalhes de OptimizeRx Corp Empresa

OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.

Informações de OptimizeRx Corp

Código da empresaOPRX
Nome da EmpresaOptimizeRx Corp
Data de listagemMay 18, 2005
CEOSilvestro (Stephen L)
Número de funcionários106
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 18
Endereço260 Charles Street
CidadeWALTHAM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal02453
Telefone12486516558
Sitehttps://www.optimizerx.com/
Código da empresaOPRX
Data de listagemMay 18, 2005
CEOSilvestro (Stephen L)

Executivos da empresa OptimizeRx Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
423.97K
+8.14%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.51K
-4.90%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
81.83K
+42.18%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
72.86K
-2.50%
Mr. Patrick D. (Pat) Spangler
Mr. Patrick D. (Pat) Spangler
Independent Director
Independent Director
68.86K
+50.12%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
66.88K
-4.03%
Ms. Catherine M. Klema
Ms. Catherine M. Klema
Independent Director
Independent Director
46.27K
+74.60%
Mr. Andy D'Silva
Mr. Andy D'Silva
Chief Business Officer
Chief Business Officer
44.73K
-3.51%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
32.73K
-5.48%
Ms. Lynn O'Connor Vos
Ms. Lynn O'Connor Vos
Independent Chairperson of the Board
Independent Chairperson of the Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
423.97K
+8.14%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.51K
-4.90%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
81.83K
+42.18%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
72.86K
-2.50%
Mr. Patrick D. (Pat) Spangler
Mr. Patrick D. (Pat) Spangler
Independent Director
Independent Director
68.86K
+50.12%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
66.88K
-4.03%

Perguntas frequentes

Quem são os cinco principais acionistas de OptimizeRx Corp?

Os cinco principais acionistas de OptimizeRx Corp são: Mr. James (Jim) Lang

Quantas instituições possuem ações da OptimizeRx Corp (OPRX)?

Em 2026Q1, 300 instituições possuíam ações da OptimizeRx Corp, com valor de mercado aproximado de 15.47M, representando 82.46% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -5161941.00.